HYPD
Hyperion DeFi, Inc.
1W: -8.4%
1M: -1.8%
3M: +11.2%
YTD: -8.7%
$3.27
-0.37 (-10.16%)
After Hours: $3.49 (+0.22, +6.57%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$18.6M
52W Range0.85-17.18
Volume380,090
Avg Volume374,415
Beta2.82
Dividend—
Analyst Ratings
Company Info
CEOHyunsu Jung
Employees13
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-07-02
Websitehyperiondefi.com/
295 Madison Avenue
New York, NY 10017
US
New York, NY 10017
US
917 289 1117
About Hyperion DeFi, Inc.
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rubenstein Robert | A-Award | 75,000 | — | 2026-01-12 |
| Rubenstein Robert | 0 | — | 2026-01-12 | |
| Knox David R. | P-Purchase | 27,950 | $3.59 | 2025-12-31 |
| Strahlman Ellen R | P-Purchase | 12,112 | $3.60 | 2025-12-29 |
| Strahlman Ellen R | P-Purchase | 11,856 | $3.61 | 2025-12-29 |